Credit Suisse Ag Ardelyx, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Ardelyx, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 271,263 shares of ARDX stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

271,263

Previous 266,336 1.85%

Holding current value

$1.44 Million

Previous $1.65 Million 19.93%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$6.05 - $9.74 $29,808 - $47,988	4,927 Added 1.85%	271,263 $1.98 Million
Q4 2023 Feb 08, 2024	BUY	$3.29 - $6.64 $194,172 - $391,886	59,019 Added 28.47%	266,336 $1.65 Million
Q3 2023 Nov 13, 2023	SELL	$3.3 - $4.83 $313,209 - $458,424	-94,912 Reduced 31.4%	207,317 $845,000
Q2 2023 Aug 11, 2023	BUY	$3.23 - $4.95 $533,983 - $818,334	165,320 Added 120.75%	302,229 $1.02 Million
Q1 2023 May 10, 2023	BUY	$2.68 - $4.79 $366,916 - $655,794	136,909 New	136,909 $655,000

Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $33,446 - $66,114	-38,891 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $3,006 - $19,338	2,367 Added 6.48%	38,891 $51,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $45,450 - $62,312	-6,939 Reduced 15.97%	36,524 $276,000
Q1 2021 May 14, 2021	SELL	$6.1 - $7.69 $254,321 - $320,611	-41,692 Reduced 48.96%	43,463 $288,000
Q4 2020 Feb 12, 2021	BUY	$5.05 - $7.1 $5,156 - $7,249	1,021 Added 1.21%	85,155 $550,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $208,330 - $280,948	-39,682 Reduced 32.05%	84,134 $442,000
Q2 2020 Aug 12, 2020	BUY	$5.37 - $8.11 $664,891 - $1 Million	123,816 New	123,816 $857,000
Q1 2020 May 13, 2020	SELL	$4.35 - $8.79 $117,319 - $237,066	-26,970 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$4.23 - $8.29 $53,276 - $104,412	12,595 Added 87.62%	26,970 $203,000
Q3 2019 Nov 12, 2019	BUY	$2.15 - $6.28 $2,700 - $7,887	1,256 Added 9.57%	14,375 $67,000
Q2 2019 Aug 14, 2019	BUY	$2.49 - $3.73 $4,434 - $6,643	1,781 Added 15.71%	13,119 $35,000
Q1 2019 May 14, 2019	BUY	$1.88 - $3.35 $21,315 - $37,982	11,338 New	11,338 $31,000
Q3 2018 Nov 13, 2018	SELL	$3.75 - $4.65 $40,811 - $50,605	-10,883 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.7 - $5.8 $25,888 - $40,582	-6,997 Reduced 39.13%	10,883 $40,000
Q1 2018 May 15, 2018	BUY	$5.05 - $7.9 $27,613 - $43,197	5,468 Added 44.05%	17,880 $91,000
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $116,487 - $187,340	-24,018 Reduced 65.93%	12,412 $82,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $63,070 - $82,644	14,499 Added 66.11%	36,430 $204,000
Q2 2017 Aug 14, 2017	BUY	N/A	21,931	21,931 $112,000

Others Institutions Holding ARDX

# of Institutions

197

Shares Held

140M

Call Options Held

1.25M

Put Options Held

1.52M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $823M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account